Clinical Trials Contact

About this Clinical Trial

Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant

Your Message Will Go To

Kelly Chyan

650-625-8130


All fields are required. *

Preferred contact method*

To:

Kelly Chyan

650-625-8130



Go Back To The Trial

We were not able to send your contact info at this time.

Go Back To The Trial

©2022 Stanford Medicine